Inventor · disambiguated record

Jeroen Geurtsen

Also filed as: GEURTSEN JEROEN · GEURTSEN JEROEN JOHANNES GERARDUS

14 granted patents·7 pending applications·22 citations·filing 2005–2025

88Inventor score

Technology areasA61K C07K A61P Y02A C12N

Files withJANSSEN PHARMACEUTICALS INC17 UNIV CHICAGO2 GEURTSEN JEROEN JOHANNES GERARDUS1 NVI NL VACCININST1

Top patents by PatentIndex Score

21 records

0192US11446370B2Bioconjugates of E. coli o-antigen polysaccharides, methods of production thereof, and methods of use thereofJANSSEN PHARMACEUTICALS INC·Filed 2020·Granted Sep 20, 2022·6 cites·42 claims
0292US11421003B2FimH mutant, compositions therewith and use thereofJANSSEN PHARMACEUTICALS INC·Filed 2021·Granted Aug 23, 2022·4 cites·25 claims
0391US12012435B2FimH mutant, compositions therewith and use thereofJANSSEN PHARMACEUTICALS INC·Filed 2022·Granted Jun 18, 2024·2 cites·15 claims
0490US11725028B2FimH mutants, compositions therewith and use thereofJANSSEN PHARMACEUTICALS INC·Filed 2022·Granted Aug 15, 2023·3 cites·33 claims
0585US11931405B2Bioconjugates of E. coli O-antigen polysaccharides, methods of production thereof, and methods of use thereofJANSSEN PHARMACEUTICALS INC·Filed 2022·Granted Mar 19, 2024·1 cites·22 claims
0680US12428449B2FimH mutant, compositions therewith and use thereofJANSSEN PHARMACEUTICALS INC·Filed 2024·Granted Sep 30, 2025·0 cites·4 claims
0780US11214600B2Compositions and methods related to antibodies that neutralize coagulase activity during Staphylococcus aureus diseaseUNIV CHICAGO·Filed 2017·Granted Jan 4, 2022·2 cites·5 claims
0878US12297238B2FimH mutants, compositions therewith and use thereofJANSSEN PHARMACEUTICALS INC·Filed 2023·Granted May 13, 2025·0 cites·20 claims
0976US12233121B2Methods of producing bioconjugates of E. coli O-antigen polysaccharides, compositions thereof, and methods of use thereofJANSSEN PHARMACEUTICALS INC·Filed 2022·Granted Feb 25, 2025·0 cites·8 claims
1072US2024316172A1Bioconjugates of e. coli o-antigen polysaccharides, methods of production thereof, and methods of use thereofJANSSEN PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
1171US8048433B2Deacylation of LPS in gram negative bacteriaNVI NL VACCININST·Filed 2005·Granted Nov 1, 2011·3 cites·32 claims
1267US2025289854A1Fimh mutants, compositions therewith and use thereofJANSSEN PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
1366US2025222093A1Methods of producing bioconjugates of e. coli o-antigen polysaccharides, compositions thereof, and methods of use thereofJANSSEN PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
1464US11491220B2Methods of producing bioconjugates of E. coli o-antigen polysaccharides, compositions thereof, and methods of use thereofJANSSEN PHARMACEUTICALS INC·Filed 2020·Granted Nov 8, 2022·0 cites·6 claims
1564US9296995B2Vaccines against Bordetella pertussis based on LPS glycosyltransferase mutantsGEURTSEN JEROEN JOHANNES GERARDUS·Filed 2008·Granted Mar 29, 2016·1 cites·18 claims
1661US2019275134A1Vaccines against urinary tract infectionsJANSSEN PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
1760US2022227819A1Compositions and methods related to antibodies that neutralize coagulase activity during staphylococcus aureus diseaseUNIV CHICAGO·Filed 2021·Application pending·0 cites
1858US12233118B2Multivalent vaccine compositions and uses thereofJANSSEN PHARMACEUTICALS INC·Filed 2021·Granted Feb 25, 2025·0 cites·25 claims
1957US12290563B2Production of E. coli 018 bioconjugatesJANSSEN PHARMACEUTICALS INC·Filed 2022·Granted May 6, 2025·0 cites·19 claims
2055US2024050546A1Variant staphylococcus aureus luka and lukb polypeptides and vaccine compositionsJANSSEN PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
2151US2025222088A1Multivalent vaccine compositions and uses thereofJANSSEN PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites

Join the waitlist — get patent alerts

Get an alert when Jeroen Geurtsen files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →